Open company graph database — free web & API
Login

China National Pharmaceutical Group Co., Ltd.

国药控股股份有限公司Kokuyaku Yakuhin Co., Ltd.Alias
Ticker
—
Listed market
—
Country
China
Employees (non-consolidated)
—
Related companies
3
§01

Basic information

BASIC
Head office
Shanghai
Chief executive
Employees (non-consolidated)
Employees (consolidated)
Start date
2003-01-01
End date
§02

Websites

1 DOMAINS
§03

Business

11
Pharmaceutical DistributionMedical Device DistributionRetail Diagnostics and TreatmentLogistics ServicesMedical Device ManufacturingPharmaceutical ManufacturingChemical ReagentsMarketing ServicesMedical ServicesIndustry-Finance IntegrationLife and Health
§04

Related companies

3 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
China National Pharmaceutical Group Co., Ltd.
Group Parent
国药一致
Group Subsidiary
国药股份
Group Subsidiary
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

21 EVENTS

China National Pharmaceutical Holdings Co., Ltd. was established in Shanghai in January 2003.Sources

Renamed to China National Pharmaceutical Holdings Ltd. on August 16, 2004.Sources

Renamed to China National Pharmaceutical Holdings Co., Ltd. on October 6, 2008.Sources

Listed in Hong Kong on September 23, 2009 (01099.HK).Sources

Revenue exceeded 100 billion in 2011.Sources

In 2013, China National Pharmaceutical Group Co., Ltd. entered the Fortune Global 500 at rank 357, and China National Pharmaceutical Holdings Co., Ltd. ranked 29th in China’s Fortune 500.Sources

Revenue exceeded 200 billion in 2014.Sources

In December 2014, it was designated as one of the first batch of mixed-ownership economic reform pilot enterprises by the State-owned Assets Supervision and Administration Commission of the State Council.Sources

Ranked 24th in Fortune China 500 in 2015.Sources

2016 Fortune China 500 Rank 22Sources

2017 Fortune China 500 Rank 22Sources

2018 Revenue exceeded 300 billionSources

2019 Revenue exceeded 425 billionSources

2020 Revenue exceeded 456 billionSources

2021 Revenue exceeded 520 billionSources

2021 Fortune China Listed Companies 500 Rank 22Sources

2022 Revenue exceeded 550 billionSources

2023 Business revenue nearly 600 billionSources

2023 Fortune China Listed Companies 500 Rank 24Sources

2023 25th Hong Kong Stock Exchange Listed Companies Golden Bull AwardSources

2023 Selected for Fortune China ESG Influence ListSources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑